Ataluren: A Novel Targeted Therapeutic Approach for the Treatment of Cystic Fibrosis

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 2

Abstract

A lethal autosomal recessive genetic disease, cystic fibrosis (CF) is most common in Caucasians and the prevalence varies with the ethnic origin of the population. Patients with CF lack adequate levels of the CF transmembrane conductance receptor (CFTR) protein, a chloride channel necessary for normal function of the lung, pancreas, liver and other organs. Nonsense (premature stop codon) mutations in mRNA for the CFTR cause CF in approximately 10% of patients. Ataluren, a protein restoration therapy, is designed to promote the translational read-through of premature stop codons that helps to overcome the nonsense mutation and enable the production of a full-length, functional CFTR protein. Insertion of a near cognate amino acid at a premature stop codon allows the protein translation to continue until one of the several stop codons normally present at the ends of mRNA transcript is reached and properly utilized. It is a “corrector” drug specific for type I mutation defects. Ataluren is a novel, orally bioavailable drug that addresses the molecular basis of the disease. Phase III Clinical trials have shown it to be efficacious and well tolerated. It represents a breakthrough in the pharmacological advances for a rare genetic disease.

Authors and Affiliations

Suruchi Aditya*| Asstt. Prof, Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh, India, Surya Kant Mathur| Professor, Department of Pediatrics, MM Institute of Medical Sciences, Mullana, Ambala, India

Keywords

Related Articles

IN VIVO HYPERGLYCEMIC EFFECT OF FAGONIA CRETICA LINN ETHANOLIC EXTRACTS ON ALBINO RATS

The use of the plants as medicines is an ancient and reliable practice. Fagonia Cretica linn is well known herbal plant used in traditional medicine of Pakistan, India and Far East, it is reputed to obtain a profitable t...

BIOLOGICAL EVALUATION OF 2-ARYLIDENE-4-(METHOXYPHENYL)BUT-3-EN-4-OLIDES

A series of 2-Arylidene-4-(methoxyphenyl)but-3-en-4-olides were screened against Pheretima posthuma earthworm for anthelmintic activity. The in vitro effects of compounds were evaluated at a concentration of 2mg/mL and t...

BIOCHEMICAL ANALYSIS OF LEAVES OF SOME MEDICINAL PLANTS OF MARATHWADA REGION IN MAHARASHTRA

The seasonal variation of chlorophyll a, chlorophyll b and carotenoid have been investigated in leaves of Butea monosperma, Madhuca indica, Syzygium cumini and Mimusops elengi are important medicinal plants. Comparativ...

PROGRESSING DIRECTED THERAPIES USING MOLECULAR IMAGING

The clinical studies that are using fluorine-18 tracers succumb to four general sorts: treatment planning, either for pharmaceutical therapy or radiation therapy; prescient or reaction marker studies for new pharmaceuti...

Download PDF file
  • EP ID EP1649
  • DOI -
  • Views 435
  • Downloads 24

How To Cite

Suruchi Aditya*, Surya Kant Mathur (2013). Ataluren: A Novel Targeted Therapeutic Approach for the Treatment of Cystic Fibrosis. Journal of Biomedical and Pharmaceutical Research, 2(2), 21-25. https://europub.co.uk/articles/-A-1649